Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.
Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. 2012 Feb; 12(1):86-92.
View in:
PubMed
subject areas
Adult
Bupropion
Cross-Sectional Studies
Dopamine Uptake Inhibitors
Double-Blind Method
Female
Genetic Variation
Genotype
Humans
Male
Middle Aged
Receptors, Dopamine D4
Smoking
Smoking Cessation
Treatment Outcome
authors with profiles
Sean P. David